{"title":"全植入式静脉通路装置 (TIVAD) 移入胸膜腔:病例报告","authors":"Fatemeh Shahrahmani , Reza Shojaeian","doi":"10.1016/j.epsc.2024.102887","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Totally implantable venous access devices (TIVADs) offer significant advantages for long-term intravenous therapy, but their use is not without potential complications. Catheter migration is one of them.</p></div><div><h3>Case presentation</h3><p>An 11-year-old boy with a primitive neuro-ectodermal tumor (PNET) undergoing chemotherapy was a candidate for a TIVAD placement. A TIVAD was implanted through the right internal jugular vein and secured to the pectoralis major in a right thoracic subcutaneous pouch without complications. Approximately six months later, port malfunction was noticed. Physical examination revealed that the port was no longer palpable, and a chest X-ray confirmed that the port was displaced. Subsequent chest X-rays showed different locations of the port and the catheter. With the hypothesis that the port had entered the pleural space and was moving freely, we did an exploratory thoracoscopy. We confirmed the intrapleural position of the port and catheter and removed both without complications. The patient was discharged four days later.</p></div><div><h3>Conclusion</h3><p>Although rare, TIVADs can migrate from the chest wall into the pleural cavity. Frequent evaluation of their function and position is critical for the early detection of complications.</p></div>","PeriodicalId":45641,"journal":{"name":"Journal of Pediatric Surgery Case Reports","volume":"110 ","pages":"Article 102887"},"PeriodicalIF":0.2000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213576624001155/pdfft?md5=b35c2212113fd61ef60e660b6d980bd9&pid=1-s2.0-S2213576624001155-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Totally implantable venous access device (TIVAD) migration into the pleural space: A case report\",\"authors\":\"Fatemeh Shahrahmani , Reza Shojaeian\",\"doi\":\"10.1016/j.epsc.2024.102887\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Totally implantable venous access devices (TIVADs) offer significant advantages for long-term intravenous therapy, but their use is not without potential complications. Catheter migration is one of them.</p></div><div><h3>Case presentation</h3><p>An 11-year-old boy with a primitive neuro-ectodermal tumor (PNET) undergoing chemotherapy was a candidate for a TIVAD placement. A TIVAD was implanted through the right internal jugular vein and secured to the pectoralis major in a right thoracic subcutaneous pouch without complications. Approximately six months later, port malfunction was noticed. Physical examination revealed that the port was no longer palpable, and a chest X-ray confirmed that the port was displaced. Subsequent chest X-rays showed different locations of the port and the catheter. With the hypothesis that the port had entered the pleural space and was moving freely, we did an exploratory thoracoscopy. We confirmed the intrapleural position of the port and catheter and removed both without complications. The patient was discharged four days later.</p></div><div><h3>Conclusion</h3><p>Although rare, TIVADs can migrate from the chest wall into the pleural cavity. Frequent evaluation of their function and position is critical for the early detection of complications.</p></div>\",\"PeriodicalId\":45641,\"journal\":{\"name\":\"Journal of Pediatric Surgery Case Reports\",\"volume\":\"110 \",\"pages\":\"Article 102887\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2024-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2213576624001155/pdfft?md5=b35c2212113fd61ef60e660b6d980bd9&pid=1-s2.0-S2213576624001155-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pediatric Surgery Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213576624001155\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Surgery Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213576624001155","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
摘要
导言完全植入式静脉通路装置(TIVAD)为长期静脉治疗提供了显著优势,但其使用并非没有潜在并发症。病例介绍 一名患有原始神经外胚层肿瘤(PNET)并正在接受化疗的 11 岁男孩是 TIVAD 植入的候选者。通过右侧颈内静脉植入了 TIVAD,并将其固定在右胸皮下袋的胸大肌上,未出现并发症。大约六个月后,发现端口出现故障。体格检查发现已无法触及端口,胸部 X 光检查证实端口移位。随后的胸部 X 光片显示端口和导管的位置不同。我们假设移植口已进入胸膜腔并可自由移动,于是进行了探查性胸腔镜检查。我们确认了接口和导管在胸膜内的位置,并在没有并发症的情况下将两者移除。结论尽管罕见,但 TIVAD 仍有可能从胸壁移入胸膜腔。经常评估其功能和位置对于早期发现并发症至关重要。
Totally implantable venous access device (TIVAD) migration into the pleural space: A case report
Introduction
Totally implantable venous access devices (TIVADs) offer significant advantages for long-term intravenous therapy, but their use is not without potential complications. Catheter migration is one of them.
Case presentation
An 11-year-old boy with a primitive neuro-ectodermal tumor (PNET) undergoing chemotherapy was a candidate for a TIVAD placement. A TIVAD was implanted through the right internal jugular vein and secured to the pectoralis major in a right thoracic subcutaneous pouch without complications. Approximately six months later, port malfunction was noticed. Physical examination revealed that the port was no longer palpable, and a chest X-ray confirmed that the port was displaced. Subsequent chest X-rays showed different locations of the port and the catheter. With the hypothesis that the port had entered the pleural space and was moving freely, we did an exploratory thoracoscopy. We confirmed the intrapleural position of the port and catheter and removed both without complications. The patient was discharged four days later.
Conclusion
Although rare, TIVADs can migrate from the chest wall into the pleural cavity. Frequent evaluation of their function and position is critical for the early detection of complications.